Around the same time, companies like Novo Nordisk began medicinal chemistry efforts to create modified human GLP-1 analogues with longer half-lives (for example, by adding fatty acid chains to help the peptide bind to albumin and resist degradation) ( [47] ) ( [48] )
This holistic approach enhances the chances of successful weight management and long-term health benefits
While LEADER and ELIXA were similar in terms of their overall design, there were some major differences between the patient populations enrolled in the two studies
Despite a continuing increase in the number of people with both [conditions], treatment options remain limited, said Jeff Emmick, senior vice president, product development, at Lilly, in a press statement
It's a reasonable supporting ingredient, not a standalone weight-loss solution
For others, it may be combined with or transitioned alongside other medications such as Qsymia, depending on how your body responds